Log in to your Inderes Free account to see all free content on this page.
Xspray Pharma
25.00 SEK
-0.60 %
Less than 1K followers
XSPRAY
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xspray Pharma
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| growth-% | |||||||
| EBITDA | -41.8 | -45.8 | -89.1 | -123.5 | -172.5 | -278.5 | -151.3 |
| EBIT | -49.7 | -53.5 | -98.0 | -133.1 | -181.7 | -287.0 | -156.9 |
| Profit before taxes | -48.9 | -52.4 | -96.7 | -131.7 | -179.7 | -285.7 | -171.6 |
| Net income | -48.9 | -52.4 | -96.7 | -131.7 | -179.7 | -285.5 | -171.4 |
| EPS | -3.01 | -2.93 | -4.83 | -6.01 | -6.56 | -8.47 | -4.46 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | |||||||
| EBIT-% | |||||||
| ROE | -13.1 % | -9.0 % | -16.3 % | -23.7 % | -25.9 % | -45.8 % | -28.4 % |
| ROI | -12.2 % | -8.7 % | -15.5 % | -22.5 % | -23.5 % | -35.9 % | -22.3 % |
Login required
This content is only available for logged in users